This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1991 Apr 18;324(16):1133-5.

doi: 10.1056/NEJM199104183241612.

Regression of coronary artery disease as a result of intensive lipid-lowering therapy

No authors listed

PMID: 2008188
DOI: 10.1056/NEJM199104183241612

Clinical Trial

Regression of coronary artery disease as a result of intensive lipid-lowering therapy

No authors listed. N Engl J Med. 1991.

. 1991 Apr 18;324(16):1133-5.

doi: 10.1056/NEJM199104183241612.

PMID: 2008188
DOI: 10.1056/NEJM199104183241612

No abstract available

PubMed Disclaimer

Comment on

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Brown G, et al. N Engl J Med. 1990 Nov 8;323(19):1289-98. doi: 10.1056/NEJM199011083231901. N Engl J Med. 1990. PMID: 2215615 Clinical Trial.

Similar articles

[Value of determining serum cholesterol levels in patients with coronary heart disease].
Stalenhoef AF. Stalenhoef AF. Ned Tijdschr Geneeskd. 1997 Dec 27;141(52):2545-8. Ned Tijdschr Geneeskd. 1997. PMID: 9555153 Review. Dutch.
Statins in the prevention of coronary heart disease.
Williamson DR, Pharand C. Williamson DR, et al. Pharmacotherapy. 1998 Mar-Apr;18(2):242-54. Pharmacotherapy. 1998. PMID: 9545143 Review.
Aggressive lipid-lowering therapy in high-risk groups: warranted or excessive?
Wierzbicki AS. Wierzbicki AS. Int J Clin Pract. 2003 May;57(4):256-7. Int J Clin Pract. 2003. PMID: 12800452 No abstract available.
[Optimal lipid lowering therapy for coronary heart diseases patients in secondary prevention: moderate or aggressive LDL decrease preferred?].
[No authors listed] [No authors listed] MMW Fortschr Med. 2006 Nov 30;148(48):54-5. MMW Fortschr Med. 2006. PMID: 17615773 German. No abstract available.
Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
Colquhoun DM. Colquhoun DM. Aust Fam Physician. 2002 Jan;31(1):25-6, 29-30. Aust Fam Physician. 2002. PMID: 11840884 Review.

See all similar articles

Cited by

The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential.
Zhang X, Zhang Y, Sun A, Ge J. Zhang X, et al. Genes Dis. 2021 Apr 24;9(4):959-972. doi: 10.1016/j.gendis.2021.04.001. eCollection 2022 Jul. Genes Dis. 2021. PMID: 35685463 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.